Jan M. Pawlicki

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Pablo Tebas, ShuPing Yang, Jean Boyer et al. · EClinicalMedicine · 2020 · 276 citations · Full text

Tissue-Specific Mitotic Bookmarking by Hematopoietic Transcription Factor GATA1

Stephan Kadauke, Maheshi Udugama, Jan M. Pawlicki et al. · Cell · 2012 · 242 citations · Full text

Functional Genomics, Cell Regulation, Tissue-specific Mitotic Bookmarking +5

Primary microRNA transcript retention at sites of transcription leads to enhanced microRNA production

Jan M. Pawlicki, Joan A. Steitz · The Journal of Cell Biology · 2008 · 148 citations · Full text

Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality

Asim Saha, Roddy S. O’Connor, Govindarajan Thangavelu et al. · Journal of Clinical Investigation · 2016 · 89 citations · Full text

Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors

Robert H. Vonderheide, Kimberly A. Kraynyak, Anthony F. Shields et al. · Journal for ImmunoTherapy of Cancer · 2021 · 42 citations · Full text